0001628280-23-024447.txt : 20230706
0001628280-23-024447.hdr.sgml : 20230706
20230706160146
ACCESSION NUMBER: 0001628280-23-024447
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anevski Peter
CENTRAL INDEX KEY: 0001576147
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39100
FILM NUMBER: 231073547
MAIL ADDRESS:
STREET 1: C/O PROGYNY, INC.
STREET 2: 1359 BROADWAY, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Progyny, Inc.
CENTRAL INDEX KEY: 0001551306
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 272220139
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 212-888-3124
MAIL ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn, Inc.
DATE OF NAME CHANGE: 20150318
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn Inc
DATE OF NAME CHANGE: 20120601
4
1
wf-form4_168867368611225.xml
FORM 4
X0407
4
2023-07-03
0
0001551306
Progyny, Inc.
PGNY
0001576147
Anevski Peter
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FLOOR
NEW YORK
NY
10018
1
1
0
0
CHIEF EXECUTIVE OFFICER
1
Common Stock
2023-07-03
4
M
0
6439
3.95
A
222363
D
Common Stock
2023-07-03
4
S
0
6439
38.78
D
215924
D
Common Stock
2023-07-03
4
S
0
1610
38.78
D
14987
I
See footnote
Stock Option (Right to Buy)
3.95
2023-07-03
4
M
0
6439
0
D
2029-05-23
Common Stock
6439.0
789117
D
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.56 to $39.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
These options are fully vested and exercisable.
/s/ Mark Livingston, Attorney-in-Fact
2023-07-06